Rajangam Kanya 4
4 · Senti Biosciences, Inc. · Filed Jul 20, 2022
Insider Transaction Report
Form 4
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
- Award
Stock Option (Right to Buy)
2022-07-18+327,750→ 327,750 totalExercise: $1.80Exp: 2032-07-17→ Common Stock (327,750 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest on July 5, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.